Segment Information by Division

2010

€ million

Silicones

Polymers

Bio-
solutions

Polysilicon

Siltronic

Other

Con-
solidation

Group

External sales

1,563.3

788.9

138.0

1,177.5

1,018.7

62.0

–

4,748.4

Internal sales

17.2

21.1

4.4

191.2

6.1

95.1

-335.1

–

Total sales

1,580.5

810.0

142.4

1,368.7

1,024.8

157.1

-335.1

4,748.4

EBIT

150.0

82.2

16.6

586.7

-3.5

-65.5

-1.9

764.6

Write-downs and impairments/write-ups of noncurrent assets

79.9

40.4

8.4

146.7

91.2

63.3

–

429.9

EBITDA

229.9

122.6

25.0

733.4

87.7

-2.2

-1.9

1,194.5

EBIT includes:
Income from investments in joint ventures and associates

-14.1

–

–

–

-24.0

0.1

–

-38.0

Impairment losses

-7.5

-3.5

-1.4

–

-0.3

–

–

-12.7

Additions to property, plant and equipment¹

92.1

13.1

6.5

309.9

63.8

115.4

–

600.8

Additions to financial assets²

0.8

–

–

–

11.7

0.6

–

13.1

Asset additions

92.9

13.1

6.5

309.9

75.5

116.0

–

613.9

Acquisitions

81.2

–

–

–

–

–

–

81.2

Assets (Dec. 31)

1,084.7

413.1

91.8

1,476.6

1,237.2

1,542.0

-344.2

5,501.2

Liabilities (Dec. 31)

524.5

172.9

36.9

1,391.0

293.9

976.1

-340.9

3,054.4

Net assets (Dec. 31)

560.2

240.2

54.9

85.6

943.3

565.9

-3.3

2,446.8

Investments in joint ventures and associates included in net assets (Dec. 31)

42.7

–

–

–

69.0

–

–

111.7

Research and development expenses

-25.3

-14.0

-3.5

-12.8

-72.3

-39.3

2.1

-165.1

Employees (Dec. 31)

3,892

1,377

363

1,763

5,025

3,894

–

16,314

Employees (average)

3,737

1,369

354

1,715

5,024

3,834

–

16,033

2009

€ million

Silicones

Polymers

Bio-
solutions

Polysilicon

Siltronic

Other

Con-
solidation

Group

External sales

1,219.2

732.7

100.5

968.1

632.6

66.2

–

3,719.3

Internal sales

19.6

11.1

4.4

153.1

4.9

114.6

-307.7

–

Total sales

1,238.8

743.8

104.9

1,121.2

637.5

180.8

-307.7

3,719.3

EBIT

33.5

77.8

4.7

414.1

-414.7

-89.9

1.3

26.8

Write-downs and impairments/write-ups of noncurrent assets

124.4

39.4

5.2

106.7

252.3

51.9

–

579.9

EBITDA

157.9

117.2

9.9

520.8

-162.4

-38.0

1.3

606.7

EBIT includes:
Income from investments in joint ventures and associates

-17.8

–

–

-74.8

-36.7

1.9

–

-127.4

Impairment losses

-36.8

-4.3

-0.2

-0.1

-139.2

-1.5

–

-182.1

Additions to property, plant and equipment¹

70.1

40.0

12.7

400.1

73.0

111.5

–

707.4

Additions to financial assets²

32.1

–

–

–

–

0.6

–

32.7

Asset additions

102.2

40.0

12.7

400.1

73.0

112.1

–

740.1

Acquisitions

–

–

–

–

–

–

–

–

Assets (Dec. 31)

907.8

400.7

86.4

1,290.0

1,114.1

1,023.7

-280.8

4,541.9

Liabilities (Dec. 31)

397.4

125.9

29.4

1,140.9

269.8

893.9

-257.8

2,599.5

Net assets (Dec. 31)

510.4

274.8

57.0

149.1

844.3

129.8

-23.0

1,942.4

Investments in joint ventures and associates included in net assets (Dec. 31)

56.6

–

–

–

83.6

–

–

140.2

Research and development expenses

-26.9

-14.2

-4.4

-11.3

-62.9

-44.3

–

-164.0

Employees (Dec. 31)

3,873

1,362

344

1,600

5,096

3,343

–

15,618

Employees (average)

3,869

1,454

302

1,484

5,238

3,372

–

15,719